Early Access Program Results From Turkey and a Literature Review on
The present study investigated the efficacy and safety profile of daratumumab monotherapy in 42 patients with relapsed refractory multiple myeloma through a Turkish early access program. The current findings have confirmed the efficacy of daratumumab monotherapy in heavily pretreated patients with r...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Review |
Language: | English |
Published: |
CIG MEDIA GROUP, LP
2020
|
Subjects: | |
Online Access: | http://hdl.handle.net/11499/38104 |